Skip to main content

Featured post

Video: "One in a Million" By Owen Cant

Updates from AHC Charities on AAV Gene Therapy: We are a bit closer to our targets !!

We want to thank our wonderful family, friends and friends of friends for your amazing response and kind donations and messages. We are overwhelmed and so very grateful.

The latest update from AAV gene therapy committee last week: As a result of fundraising efforts, there is approx. $250,000-300,000 to fund the April step of the Project.
We are that bit closer to the $500,000 target.
Every £1/$1 counts.

Thank you SO much for your donations! 

Please keep sharing.

JustGiving - Sponsor me now!





-----------------

Updates statement from 3 AHC Charities (Alternating Hemiplegia of Childhood Foundation, Cure AHC and Hope for Annebel) 


Image may contain: text that says "AAV Project Update"
As we pass the six month milestone for the AAV Project, we wanted to provide the AHC community with a brief update and some clarity about next steps. Since June 2018, Cure AHC, AHC Foundation and Hope for Annabel have been collaborating on a gene therapy effort using Adeno Associated Virus (AAV) as a delivery system for functioning ATP1A3 to compensate for the mutated ATP1A3 associated with AHC. Our collaboration has involved pooling our financial resources and leveraging connections with scientists around the world to work together.

To eventually and hopefully get to a clinical trial with AHC patients, the AAV Project will have several phases with multiple steps in each phase. We are in just the first phase of the AAV Project where we aim to develop a viral vector to deliver extra ATP1A3 in mice to assess whether AHC symptoms improve after treatment.
In Phase One, the three foundations, along with contributions from AHC organizations in UK and Ireland, have already funded over $225,000 to complete the following steps:
1) Partnered with Dr. Steve Gray at UT-Southwestern who will help us lead the AAV Project – completed October 2018
2) Designed and produced four viral vectors to deliver functioning ATP1A3 – completed November 2018.
3) Injected non-diseased mice using the four viral vectors to deliver functioning ATP1A3 – completed November 2018
4) Assess which vector did the best job in delivering extra ATP1A3 to targeted areas of the mouse brain – started December 2018 and will be done March 2019

The next step will cost approximately $500,000 and is scheduled to start April 1, 2019 at the Jackson Labs. We will be selecting the best performing vector to deliver extra ATP1A3 to mice with AHC, and then perform a variety of behavior experiments to see whether the AHC symptoms show improvement. If the AAV treatment shows significant improvement in the mice with AHC, we would be on our way to the next phase of testing and closer to a clinical trial.
As a result of fundraising efforts, Cure AHC, AHC Foundation and Hope for Annabel have around $250,000-300,000 currently available to fund this next step of the AAV Project. While we are hopeful that continued fundraising will result in filling the gap in the coming weeks, we need every family to keep contributing to this effort.
Families and organizations wanting to support the AAV Project should feel comfortable directing fundraising efforts to one, two or all three of the foundations: Cure AHC, AHC Foundation or Hope for Annabel.
For questions about the AAV Project or specific fundraising efforts, please contact Jeff Wuchich (jeff@cureahc.org), Lynn Egan (lynn@ahckids.org) and Simon Frost (simon@tibercapital.com).
To donate and help us reach our goal, click www.ahckids.org
Thanking you in advance for your support.

-------------------------



Comments

Popular posts from this blog

‘One in a million’ Edinburgh toddler set for rare disease trial in US: Reports Edinburgh Evening News

We were interviewed by the Edinburgh Evening News where they highlighted Anya's rare medical condition. I have attached the report on this post. The Edinburgh Evening News report was written by Kevan Cristie ‘One in a million’ Edinburgh toddler set for rare disease trial in US KEVAN CHRISTIE Katherine Behl with her 18-month daughter, Anya, with dad Abhishek. Pic: Lisa Ferguson The family of an 18-month-old toddler who has a condition so rare it only affects one person in a million are raising funds for a groundbreaking gene therapy project in the US.  Anya Behl, suffered her first episode of what would later be diagnosed as Alternating Hemiplegia of Childhood (AHC) at 10 weeks old in October 2017. Those with the lifelong condition are described as ‘human timebombs’ as the illness which is like having seven diseases at once - including stroke like paralysis and symptoms of Parkinson’s disease, can strike at anytime.  Her parents Abhishek and Katherine told how everyth

Creative WWF Wildlife Adverts that make you Save Our Planet

We always know that good advertising plays a key role in ones responsible development. Wildlife charities have worked very hard to be creative, and to pass a good message to their viewers about saving our planet. How important it is for us humans to start thinking and start saving our wilderness as we live in and what is around us.  ---- Some of the very powerful adverts are from  WWF campaigns . For those who have not a clue to what what WWF is all about: Here we go -  WWF  (World Wide Fund for Nature) is an organization which mission is to stop the degradation of our planet’s natural environment, and build a future in which humans live in harmony with nature. WWF was founded in 1961. It was the product of a deep concern held by a few eminent gentlemen who were worried by what they saw happening in our world at that time. Since those early days WWF has grown up to be one of the largest environmental organizations in the world. (more on  Wiki ) Below we list WWF ads. Hope you’

Signing up to Alternating Hemiplegia of Childhood (AHC) UK Newsletter.

Yes people, It is finally here and we are working on sending out updates to various people about Alternating Hemiplegia of Childhood UK via a newsletter and the chair's update.  If you would like to be involved and to be kept informed about the various updates that are happening with AHC in the UK and all over the world -  Please sign up to the new AHC UK Newsletter for updates ( Click on & add your name/email on this attached link : http://eepurl.com/gD2M3n ) We look forward in sharing our updates with you all.

Anya is 1 in a million: Funding for all AHC Kids & Gene Therapy Research

We are so grateful for all the amazing support, messages and generous donations to research from our wonderful family and friends in 2018.  A  heartfelt thanks. We have been blown away by your kindness!   In February 2018 at 6 months old, Anya was given the diagnosis of  Alternating Hemiplegia of Childhood (AHC) after genetic testing for the  ATP1A3 gene. This is an extremely rare condition, affecting one in a  million; it arises from a chance, non-inherited error. It is something we  had neither heard of nor something we could ever have envisaged our  precious first-born having to struggle with. It’s been a very difficult year and we’ve seen symptoms (sometimes life-threatening) that we wouldn’t wish any parent to witness.  AHC has effects beyond the neurological ones and sadly Anya has had breathing and cardiac difficulties too. Almost all children with AHC have physical, cognitive and developmental disabilities across a spectrum. By the age of two 50% have epilepsy; and